This model encompasses a role for inflammatory mediators, tumor-derived cytokines, and hypoxia in activating STAT3, SMAD2/4, NFκB, and HIF1 signaling in myeloid cells [15,26,38,43-46]. The gene discussed is SMAD2; the disease is neoplasm.